BDNF and Alzheimer disease: The peptides showed relatively low toxicity on the RA/BDNF-differentiated cells in vitro, which is in agreement with the slow progression of AD, however, a question may arise about the biological relevance of the effects observed at extremely high concentrations of these effectors.